Letters of Intent for the 2026 grants cycle are being accepted until December 1, 2025.
PSC Partners highly encourages patient partnership even in early-stage or basic science research by providing training to PSC community members to become patient partnership representatives and providing guidance documents, partnership planning templates, and consultations with its research staff for potential grant applicants.
PSC Partners and affiliate PSC Partners Canada offer Standard Seed Grants and Young Investigator Awards annually to conduct research that addresses an important and novel, basic or clinical research question related to PSC and closely associated diseases (such as inflammatory bowel diseases (IBD) and cholangiocarcinoma).
Our Research Grants Program seeks to encourage investigators to conduct research in promising new areas, with the goal that data generated will lead to federal (NIH) or external international funding.
The 2025 grant cycle marked a record-breaking year for PSC Partners and PSC Partners Canada, with 43 Letters of Intent and 38 full applications received.
From this highly competitive pool, five groundbreaking research grants were awarded—two Standard Seed Grants and two Young Investigator Awards in the US and one Standard Grant funded in Canada—to advance our understanding of PSC.
